Department of Laboratory Medicine & Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610213, Sichuan, China.
Anal Chem. 2024 Oct 22;96(42):16499-16504. doi: 10.1021/acs.analchem.4c03922. Epub 2024 Oct 9.
Accurate diagnosis of highly aggressive and deadly tumors is essential for effective treatment and improved patient outcomes, and microRNAs (miRNAs) have emerged as crucial biomarkers for their roles in tumor initiation, progression, and metastasis. Herein, we present an on-site visualization colorimetric assay for tumor-associated miRNAs using ruthenium nanoparticle decorated titanium dioxide nanoribbon (Ru@TiO) as a peroxidase-like (POD) nanozyme. Remarkably, the Ru@TiO nanozyme can catalyze the oxidation of chromogenic substrates through its POD-like activity, which is effectively inhibited by pyrophosphate generated during the rolling circle amplification process, thereby enabling miRNA detection through a visible colorimetric readout. This approach provides a highly sensitive and specificity assay for miRNAs in diluted human serum with a detection limit of 100 pM. It shows great potential for clinical diagnostics and biological research, offering a promising tool for early cancer diagnosis and molecular diagnostics.
准确诊断高度侵袭性和致命性肿瘤对于有效治疗和改善患者预后至关重要,而 microRNAs(miRNAs)已成为肿瘤发生、进展和转移的关键生物标志物。在此,我们提出了一种使用钌纳米粒子修饰的二氧化钛纳米带(Ru@TiO)作为过氧化物酶样(POD)纳米酶的用于肿瘤相关 miRNAs 的现场可视化比色分析方法。值得注意的是,Ru@TiO 纳米酶可以通过其 POD 样活性催化显色底物的氧化,而焦磷酸根的生成在滚环扩增过程中有效地抑制了这一过程,从而可以通过可见比色读出进行 miRNA 检测。该方法为稀释后的人血清中的 miRNAs 提供了一种高灵敏度和特异性的检测方法,检测限低至 100 pM。它在临床诊断和生物研究方面具有巨大的潜力,为早期癌症诊断和分子诊断提供了一种有前途的工具。